Immune-related adverse events as a predictor marker of response to programmed cell death 1/programmed death-ligand 1 axis inhibitors in patients with non-small cell lung cancer

EUROPEAN RESPIRATORY JOURNAL(2021)

引用 0|浏览6
暂无评分
关键词
Lung cancer - management, Immunology, Lung cancer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要